Determination of sympathetic vasodilator responses during renal nerve stimulation.
D000109:Acetylcholine / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001949:Bretylium Compounds / Q000494:pharmacology; D004285:Dogs; D004558:Electric Stimulation; D005260:Female; D006145:Guanethidine / Q000494:pharmacology; D007668:Kidney / Q000098:blood supply / Q000294:innervation*; D008297:Male; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects*; D013564:Sympathetic Nervous System / Q000502:physiology*; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D001949:Bretylium Compounds; D011453:Prostaglandins; D014665:Vasodilator Agents; D010643:Phenoxybenzamine; D011433:Propranolol; D000109:Acetylcholine; D006145:Guanethidine